Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:58 PM
Ignite Modification Date:
2025-12-24 @ 2:58 PM
NCT ID:
NCT03511859
Eligibility Criteria:
Inclusion Criteria:
* All subjects need to sign the informed consent form and age is above 20.
* Control group need to have mammogram /ultrasound results category1-3 and confirmed by PI.
* Cancer group subjects with pathology report confirmed to be malignant have not yet done surgery or treatment will be enrolled to the malignant group for analysis
Exclusion Criteria:
* Not willing to sign the informed consent form
* Have been undergone general anesthesia or regional anesthesia in 1 month
* Have been diagnosed with any type of cancer and been treated
* Have been suffering from autoimmune disorder such as SLE and RA
* Have been suffering from chronic infection such as IBD, pancreatitis, COPD or Interstitial pneumonia.
* Have been suffering from acute infection or other infectious diseases in 3 moths such as TB, pneumonia, urinary tract infection, or cellular infection
* Diagnosed with myelodysplastic syndrome or myeloproliferative diseases
* Other condition which may affect the CTC results, when determined by PI can be confirmed by other tests are if necessary
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT03511859
Study Brief:
Protocol Section:
NCT03511859